Pharmacy and Drug Information
Pharmacy Updates
08/2021 – Notice of Changes to the Formulary.
01/2021 – 2021 Provider Notification of Opioid Drug Management Program.
12/2020 – Warning on Concurrent use of Opioids and Benzodiazepines.
11/2020 – 2021 Formulary Update.
02/2020 – Newsletter – Provider Formulary Updates.
11/2019 – 2020 Provider Notification of Opioid Drug Management Program (DMP).
11/2019 – HHS Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use.
07/2019 – Newsletter – Provider Formulary Updates.
12/2018 – 2019 Provider notification of Opioid Drug Management Program.
Provider Prevention of Unauthorized Prescribing
To learn more click below:
- CMS: Partners in Integrity-What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs https://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/provider-education-toolkits/downloads/prescriber-role-drugdiversion.pdf
- E-FORCSE®, Florida’s Prescription Drug Monitoring Program Home Page http://www.floridahealth.gov/statistics-and-data/e-forcse/
Influenza Season 2020-2021 Update
Recalls and Drug Safety Communications
08/2021 – Drug Recall Notice Chantix tablets.
07/2021 – Drug Recall Notice Metformin HCl Extended-Release Tablets, USP 750 mg.
05/2021 – Drug Recall Notice NP Thyroid tablets.
02/2021 – FDA Drug Safety Communication: Xeljanz, Xeljanz XR.
02/2021 – Drug Recall Notice Enoxaparin Sodium Inj. by Apotex.
07/2020 – Drug Recall Notice Granule Pharmaceuticals Metformin Hydrochloride ER 750 mg tablets.
06/2020 – Drug Recall Notice Teva Metformin Hydrochloride ER 500 mg and 750 mg tablets.
06/2020 – Drug Recall Notice Amneal Metformin Hydrochloride ER 500 mg and 750 mg tablets.
05/2020 – Drug Recall Notice NP Thyroid tablets.
04/2020 – Drug Recall Notice Tetracycline 250mg and 500mg capsules.
04/2020 – Drug Recall Notice ALL Ranitidine and ZANTAC products.
01/2020 – Drug Recall Notice Ranitidine 150mg and 300mg capsules (Appco)
01/2020 – Drug Recall Notice Aurobindo Mirtazapine 7.5 mg tablets lot #03119002A3
12/2019 – Drug Recall Notice Expansion Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup
11/2019 – Drug Recall Notice Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup
11/2019 – Drug Recall Notice Novitium Ranitidine 150 mg and 300 mg tablets
11/2019 – Drug Recall Notice Lannett Ranitidine 15mg/mL syrup
10/2019 – Drug Recall Notice Mylan Alprazolam products
10/2019 – Drug Recall Notice Dr. Reddy’s Ranitidine products
10/2019 – Drug Recall Notice Sandoz Rantidine Capsules
10/2019 – FDA Drug Safety Communication – Zantac (Ranitidine)
09/2019 – Drug Recall Notice – NATPARA (Parathyroid Hormone) for Injection
09/2019 – FDA Drug Safety Communication: Xeljanz, Zeljanz XR
08/2019 – Over the Counter (OTC) recall of multiple Altaire Ophthalmic products at CVS
08/2019 – Drug Recall Notice Relpax 40 mg tablets
07/2019 – Drug Recall – Altaire Pharmaceuticals – Ophthalmics
05/2019 – Drug Recall Notice Losartan and Losartan HCTZ
05/2019 – Drug Recall Losartan
05/2019 – FDA Drug Safety Communication for Prescription Insomnia Medicines: New Boxed Warning – Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake
04/2019 – Drug Recall Notice – Losartan Legacy MFXR
04/2019 – Drug Recall Notice – Valsartan
04/2019 – Drug Recall Notice Losartan and Losartan HCTZ
04/2019 – Drug Recall Notice Losartan
04/2019 – Drug Recall Notice Losartan HCTZ
01/2019 – Drug News and Alerts/ Recall Notice for Irbesartan and Irbesartan HCTZ Tablets.
01/2019 – Drug News and Alerts/Recall Notice for Losartan Potassium tablets.
H4140_PRWSNOTIF_C
Last Updated: 09/10/2021